Back to Our Team

  • FORTUNE 30 GENERAL MANAGEMENT
  • Global Operations/Emerging Markets
  • Woman’s Health
  • M&A/ JV’s
  • Board Experience
  • Business Turnarounds

Clover is a senior leader widely recognized across a broad range of industries as an innovative, inspiring, globally focused board level executive that consistently delivers exceptional financial, operational and strategic outcomes. She has the demonstrated ability to turn around declining businesses, build both new and mature brands, create accretive mergers/acquisitions/joint ventures across global geographies, provide multi-cultural perspective, and inspire passionate leadership. Her core assets also include financial management strength running large complex P&L’s; international market perspective to build global strategic and tactical plans; ability to build diverse, performance-based cultures/high performance teams; capacity to drive growth through new product innovation combined with outstanding marketing programs; and record of leading significant cost containment initiatives.

In her most recent position as General Manager CPC Beauty Business at Johnson & Johnson, Clover directed the P&L for a portfolio of eight consumer and professional Beauty brands in the U.S. in multiple channels with over $1B in revenues – operating in a highly complex matrix organization with over 400 employees and 70% of the manufacturing outsourced. In this role she increased revenues 21% and IBT + 7 pts., drove point of sale growth in Food, Drug, Mass Merch channels 11%, integrated two acquisition brands into the company and reversed their declines, designed and implemented an end to end new product process, and led the Global Diversity and Inclusion Council for Johnson & Johnson Beauty. Additionally, she led the Management Board of the Division.

In her previous J&J role, Clover was Worldwide Vice President, Woman’s Health Franchise, where she led the global P&L of the $1.3B Woman’s Health Franchise and transformed the strategic plan to a global portfolio strategy that changed a regionally run business to a true “glocal” enterprise model. Her accomplishments included leading an expansion into higher margin/higher growth new categories, leveraging the expertise of J&J’s medical device and pharmaceutical divisions in new product development, developing new global structures/processes to facilitate the transfer of “best practices” across all functions, and leading two acquisitions and a licensing deal.

Prior to her career with J&J, Clover was with Schering-Plough Healthcare Products, where she was Strategic Business Unit Head/Vice President Marketing Footcare, heading up the $455MM Footcare Business Unit with a marketing budget of $100MM and staff of 18. In this role she grew the total business 18% and profit dollars 28% in four years through a major restage of the entire Dr. Scholl’s business model.

Earlier career-building leadership roles include her position as Vice President Marketing/Bali Company at the Sara Lee Corporation (annual sales of $350MM and a marketing budget of $60MM) where she grew total department store business sales 21% and profits +69%. Prior to Sara Lee, Clover had a 13 year “first career” at Johnson & Johnson where she held increasingly responsible global senior positions including Vice President – Worldwide, President, General Manager/Incontinence, Director of Marketing – Worldwide, and Director of Marketing – Personal Products Company.

Clover received her MBA in Marketing, her MA in Development Psychology, and her BA in American Studies, all from Columbia University.